SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
Location: Grand Ballroom East, 3rd Floor
Moderators: TBD
Moderators: TBD
1:00 PM - 1:05 PM
Are We Over Treating Patients With AAA: Which Patients Should NOT Be Treated Invasively Based On Frailty, Comorbidities, Anatomy And Aneurysm Size
Presenter(s): Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS Location: Grand Ballroom East, 3rd Floor
1:06 PM - 1:11 PM
Should We Reconsider AAA Size Threshold For Infrarenal AAA: Why Many Patients With AAAs >5cm In Diameter Should NOT Have Any Invasive Treatment: Should The Guidelines Be Changed
Presenter(s): Grace J. Wang, MD, MSCE / Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Grand Ballroom East, 3rd Floor
1:12 PM - 1:17 PM
Size Thresholds For Repair Of AAAs Are Wrong On The Low Side: Data From Medicare And The VQI Indicate That Rupture Risk Only Increases With AAAs Over 6-6.9 cm
Presenter(s): David H. Stone, MD / Sal Scali, MD / Bjoern D. Suckow, MD Location: Grand Ballroom East, 3rd Floor
1:18 PM - 1:23 PM
Are We Overtreating AAAs: The Current Diameter Thresholds For AAA Repair (5.5 cm For Men; 5.0 cm For Women) Are No Longer Relevant: Based On New Scrutiny Of Old Trials And A Meta-Analysis Of AAA Rupture Risk
Presenter(s): Timothy A. Resch, MD, PhD Location: Grand Ballroom East, 3rd Floor
1:24 PM - 1:29 PM
Update On Medical Treatment Trials To Slow AAA Growth: What Treatments Or Drugs Show Promise And Why: What About Metformin And The MAAAGI And MAT Trials
Presenter(s): Ronald L. Dalman, MD / Anders Wanhainen, MD, PhD Location: Grand Ballroom East, 3rd Floor
1:30 PM - 1:35 PM
If Type 2 Endoleaks, Which Are Common After EVAR, Are So Dangerous, Where Are All The Post EVAR Rupture From Them: Maybe They Aren't So Dangerous: When Must They Be Treated
Presenter(s): Jan D. Blankensteijn, MD Location: Grand Ballroom East, 3rd Floor
1:36 PM - 1:41 PM
Panel Discussion
Location: Grand Ballroom East, 3rd Floor 1:42 PM - 1:47 PM
When Is EVAR An Effective Treatment For Infected AAAs: Incidence, Pattern, And Prevention Of Recurrent Infection After EVAR For Infected AAAs: From A 20-Year Experience With >180 Cases
Presenter(s): Boonprasit Kritpracha, MD Location: Grand Ballroom East, 3rd Floor
1:48 PM - 1:53 PM
Computer Analysis Of CT Factors Determining AAA Wall Weakness/Strength Of Areas In AAAs Predicts Rupture Risk Independent Of Size And Post EVAR Neck Behavior: The ViTAA System
Presenter(s): Adam Beck, MD / Randy D. Moore, MD Location: Grand Ballroom East, 3rd Floor
1:54 PM - 1:59 PM
High Dose Statin Therapy Has A Profound Influence On The Clinical Course Of AAA Disease: From Two Prospective Screening Trials
Presenter(s): Jes S. Lindholt, MD Location: Grand Ballroom East, 3rd Floor
2:00 PM - 2:05 PM
New Endovascular Technology (Nectero — Intra-Sac Drug After AAA Balloon Isolation) To Slow AAA Growth: Updated Clinical Results Of The First-In-Human (FIH) Trial And The stAAAble RCT
Presenter(s): Andrew Holden, MBChB / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Daniel G. Clair, MD / Venkatesh G. Ramaiah, MD Location: Grand Ballroom East, 3rd Floor
2:06 PM - 2:11 PM
Unexpected Small Bowel Necrosis When Performing EVAR In Patients With Visceral Artery (SMA) Occlusive Disease: How To Predict It And How To Avoid It
Presenter(s): Karan Garg, MD / Neal S. Cayne, MD / Carlos H. Timaran, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor
2:12 PM - 2:17 PM
Comparison Of Long-Term Survival After Open And Endo AAA Repairs: Does It Help To Build A Case For Raising The Size Threshold For AAA Repair
Presenter(s): Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor
2:18 PM - 2:23 PM
AAA Treatment And Outcomes For Women: There Are Dramatic Differences Compared To Men
Presenter(s): Jon S. Matsumura, MD Location: Grand Ballroom East, 3rd Floor
2:24 PM - 2:30 PM
Panel Discussion
Location: Grand Ballroom East, 3rd Floor 2:30 PM - 2:40 PM
Break — Visit Exhibits And Pavilions (2nd and 3rd Floors)